Location: Indianapolis, Indiana, USA.
Department affected: Research and Development.
Based on news reporting.
Eli Lilly and Company has announced layoffs affecting approximately 300 employees in its Research and Development department, effective October 1, 2023. This decision comes as part of a broader restructuring effort aimed at streamlining operations and reducing costs amidst increasing competition in the pharmaceutical industry. The layoffs are expected to impact various projects and may delay some ongoing research initiatives. Eli Lilly's management stated that these changes are necessary to maintain the company's competitive edge and ensure long-term sustainability. The affected employees will receive severance packages and support for job placement.
Eli Lilly and Company cut 300 jobs affecting its Research and Development team as of October 1, 2023.
That is roughly 0.7% of the 43,000 people Eli Lilly and Company employs.
Anonymous by default. Be kind — people reading this may be going through it right now.
Eli Lilly and Company cut 300 jobs on October 1, 2023. Were you affected, or do you know people who were? How was it handled — severance, notice, which teams? You can post anonymously below.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →